Stryker Bets On OP-1 Putty After Encountering A Tough Orthopedic Climate

Stryker says that its OP-1 Putty bone morphogenetic protein will sustain growth levels as its hips and knee products encounter an increasingly challenging pricing environment

More from Archive

More from Medtech Insight